8-K
filed November 21, 2022, 6:59 PM ET
ticker EAT
CIK 0000703351
other
confidence high
sentiment neutral
materiality 0.15
Brinker International shareholders elect all 9 nominees, approve say-on-pay, ratify KPMG, reject antibiotic proposal
BRINKER INTERNATIONAL, INC
- All 9 management director nominees elected; highest vote withheld for James Katzman (31,672 withheld).
- Ratification of KPMG as independent auditor for FY2023 approved with 40.0M for, 0.5M against.
- Executive compensation (say-on-pay) approved with 36.1M for, 1.1M against.
- Amendment to 1999 Stock Option Plan for Non-Employee Directors approved with 36.6M for.
- Shareholder proposal on antibiotic use in beef/pork supply chain not approved, with 28.9M against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BRINKER INTERNATIONAL, INC shareholders approved Approval of executive compensation at the 2022-11-17 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2022-11-17
Exact text from the filing
Proposal 3 The proposal on executive compensation was approved. The results were as follows: For Against Abstain Broker Non-Vote 36,119,618 1,142,859 35,761 3,247,062
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BRINKER INTERNATIONAL, INC shareholders approved Ratification of Appointment of KPMG LLP as Independent Auditors for Fiscal 2023 at the 2022-11-17 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-11-17
Exact text from the filing
Proposal 2 The proposal to ratify the appointment of KPMG LLP as Independent Auditors for Fiscal 2023 was approved. The results were as follows: For Against Abstain Broker Non-Vote 40,004,635 519,688 20,977 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BRINKER INTERNATIONAL, INC shareholders approved Amendment of Company’s 1999 Stock Option and Incentive Plan for Non-Employee Directors and Consultants at the 2022-11-17 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2022-11-17
Exact text from the filing
Proposal 4 The proposal on amendment of Company’s 1999 Stock Option and Incentive Plan for Non-Employee Directors and Consultants was approved. The results were as follows: For Against Abstain Broker Non-Vote 36,563,813 694,949 39,476 3,247,062
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BRINKER INTERNATIONAL, INC shareholders approved Election of Directors at the 2022-11-17 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-11-17
Exact text from the filing
Proposal 1 Each of management’s nominees was elected as a director to hold office until the next Annual Meeting of Shareholders or until his or her successor is elected and qualified. Number of Shares Voted Name For Against Withheld Broker Non-Vote Frances L. Allen 37,142,225 130,399 25,614 3,247,062 Cynthia L. Davis 37,127,190 145,958 25,090 3,247,062 Joseph M. DePinto 36,465,382 806,421 26,435 3,247,062 Harriet Edelman 36,691,977 582,920 23,341 3,247,062 William T. Giles 37,136,374 137,514 24,350 3,247,062 Kevin D. Hochman 37,204,742 69,293 24,203 3,247,062 Ramona T. Hood 37,191,728 82,509 24,001 3,247,062 James C. Katzman 37,060,158 206,408 31,672 3,247,062 Prashant N. Ranade 37,134,939 136,733 26,566 3,247,062
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BRINKER INTERNATIONAL, INC shareholders rejected Shareholder proposal requesting a report on measures the Company is taking to end the use of medically important antibiotics in the Company’s beef and pork supply chain at the 2022-11-17 meeting.
- Outcome
- failed
- Meeting
- 2022-11-17
Exact text from the filing
Proposal 5 The shareholder proposal requesting a report on measures the Company is taking to end the use of medically important antibiotics in the Company’s beef and pork supply chain was not approved. The results were as follows: For Against Abstain Broker Non-Vote 7,993,341 28,913,456 391,441 3,247,062
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.